Myriad myRisk Hereditary Cancer
Category: Gene & Biotech Services
Exhibitor: GENOMICS BIOSCIENCE AND TECHNOLOGY CO., LTD.
Booth No: M308
‧ A 25-gene panel for the identification of clinically significant mutations impacting inherited risks for eight important cancers: breast, colorectal, ovarian,endometrial,
gastric, pancreatic, melanoma and prostate.
‧ Blends genetic test status AND personal/family cancer history into clinically significant risk assessment and follow-up.
‧ Provides specific management recommendations for patients testing positive AND negative based on guidelines of leading professional medical societies.
‧ >99.92% Validated Analytical Sensitivity
‧ Technical method is using NGS, Sanger sequencing and large rearrangement analysis.
Products you may be interested in